Ellen S. Chan - Concepedia

Concepedia

Author

Ellen S. Chan

Harvard University ORCID

Also Known As

Bosch, Ronald J., Brown, Todd, E Chan, E. Chan, Ellen Chan, Ellen S Chan, Ellen S. Chan, Ellen S. Chan, Evan Chan, Landay, Alan L.

46

Publications

2.4K

Citations

20

H-Index

32

Concepts

All Affiliations

Harvard University University of North Carolina at Chapel Hill National Institute of Allergy and Infectious Diseases Massachusetts General Hospital Case Western Reserve University

ES

About

Ellen S. Chan is an author at Harvard University specializing in hiv, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	721
2	Immunology	3	3	702
3	Public Health	1	1	19
4	Epidemiology	1	1	19
5	Health Policy	1	1	19

Ellen S. Chan

×

24

Publications

2.4K

Citations

20

H-Index

	Year	Citations
Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1 Angela Meier, J. Judy Chang, Ellen S. Chan, Nature Medicine Innate Immune SystemImmunologyImmune RegulationImmunodominanceInnate Immunity	2009	577
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, PLoS Medicine	2010	306
Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384 Gregory K. Robbins, John Spritzler, Ellen S. Chan, Clinical Infectious Diseases	2009	226
Effect of Baseline- and Treatment-Related Factors on Immunologic Recovery After Initiation of Antiretroviral Therapy in HIV-1-Positive Subjects Rajesh T. Gandhi, John Spritzler, Ellen S. Chan, JAIDS Journal of Acquired Immune Deficiency Syndromes	2006	159
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation Edgar T. Overton, Ellen S. Chan, Todd T. Brown, Annals of Internal Medicine	2015	118
Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa‐2a in HIV‐1–Monoinfected Participants: A Phase II Clinical Trial David M. Asmuth, Robert L. Murphy, Susan L. Rosenkranz, The Journal of Infectious Diseases	2010	118
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy Rajesh T. Gandhi, Robert W. Coombs, Ellen S. Chan, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	107
Higher Expression of Several Interferon-Stimulated Genes in HIV-1-Infected Females After Adjusting for the Level of Viral Replication J. Judy Chang, Matt Woods, Robert Lindsay, The Journal of Infectious Diseases	2013	106
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy Rajesh T. Gandhi, David O’Neill, Ronald J. Bosch, Vaccine VaccinationHiv-1-infected PatientsHuman RetrovirusImmunologyAntiviral Response	2009	89
Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy – ACTG A5286 Allan R. Tenorio, Ellen S. Chan, Ronald J. Bosch, The Journal of Infectious Diseases	2014	77

Page 1